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1. Introduction 
Previous work demonstrated that in a spectrum of 
hepatomas of different growth rates the key enzymes 
of glycolysis increased and the key enzymes of glu- 
coneogenesis decreased in parallel with tumor growth 
rate [1]. It was also shown that the two enzymes of 
the pentose phosphate pathway, glucose-6-phosphate 
dehydrogenase [2] and transaldolase [3], that are in- 
volved in the channeling of glycolytic intermediates 
into pentose phosphate biosynthesis were increased in 
all hepatomas. The metabolic onsequences of these 
alterations in the reprogramming of gene expression 
in hepatoma cells should be an increase in glycolysis 
and ribose-5-phosphate production. Isotope studies 
demonstrated that in rapidly growing liver tumors 
there was an increase in the glycolytic and in the direct 
oxidative pathway [4] and in the incorporation of 
precursors into the de novo synthesis of purine ribo- 
nucleotides [5]. 
A stepping up of ribose-5-phosphate synthesis and 
utilization in the rapidly growing neoplasms might 
also entail an increase in certain enzymes involved in 
channeling this metabolite into purine biosynthesis. 
In order to test this prediction the first enzyme 
committed to routing ribose-5-phosphate into de novo 
purine biosynthesis, phosphoribosylpyrophosphate 
(PRPP) synthetase was studied. The action of PRPP 
synthetase (ribosephosphate pyrophosphokinase, EC 
2.7.6.1) converts ribose-5-phosphate, in presence of 
ATP, into PRPP and AMP. In turn, PRPP is a key 
precursor in purine, RNA and DNA biosynthesis. 
In this communication we report hat PRPP syn- 
thetase activity was markedly increased in rapidly 
growing hepatomas, in contrast, he activity was low 
in the differentiating liver and was in normal range in 
the regenerating liver. The kinetic properties of PRPP 
synthetase were compared in tissue extracts of liver 
the hepatomas nd the activity of the enzyme of 
various organs was contrasted with that observed in 
liver. 
2. Materials and methods 
2.1. Animals and tissues 
Male Buffalo and ACI/N rats were maintained in
separate cages with water and Purina chow available 
ad libitum. The handling of the tumorbearing rats, 
preparation of the regenerating liver, studies on deve- 
loping animals, killing of the rats and excision of 
livers and tumors were carried out as reported pre- 
viously [1,2]. 
2.2. Preparation of  extracts for enzyme assay 
Ten percent homogenates (w/v) were prepared from 
the liver and tumor tissues in 0.1 M potassium phos- 
phate buffer, pH 7.4, containing 1mM dithioerythri- 
tol. To 6 ml of clear 100 000 g supernatant fluid 1.4 g 
solid ammonium sulfate was added (40% saturation). 
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After standing at 0°C for 15 min it was centrifuged at 
100 000g for 10 min. The precipitate was dissolved 
in 0.3 ml of 0.1 M potassium phosphate buffer and 
1 mM dithioerythritol, pH 7.4, recentrifuged at 12 000 
g for 10 min and used for the PRPP synthetase assay. 
2.3. The PRPP synthetase assay system 
For the enzyme assay the methods of Kornberg et 
al. [6] and Flaks [71 were adapted to the conditions 
of the liver and the hepatoma systems. A standard 
assay, the kinetic details of which will be published 
elsewhere [8], was established for determination f 
liver and hepatoma enzyme activities. In this assay 
proportionality with the amount of enzyme added and 
with length of reaction time over a 15-min period was 
achieved. 
In the two-step assay procedure PRPP is accumu- 
lated in step I and is quantitatively converted to 
orotidylic and uridylic acid in step II by addition of 
ancillary enzymes. The disappearance of orotate in 
step II was followed in a Gilford Model 2000 spectro- 
photometer at295 nm at 25°C. 
Step I. 
The incubation mixture contained in a final volume 
of 1 ml 2 mM ATP, 1 mM ribose-5-phosphate, 5 mM 
MgC12 (added after ATP and phosphate), 50 mM po- 
tassium phosphate in 50 mM Tris-HC 1 buffer, pH 
8.9. The reaction was started by addition of liver 
(0.60 mg protein) or tumor (0.48 mg protein) extracts 
and incubated at 37°C for 10 min; the reaction was 
terminated by boiling for 60 sec at 100°C. (During 
this treatment less than 2% of PRPP was decomposed 
and this was taken into consideration i  calculating 
the PRPP synthetase activity.) The tubes were imme- 
diately cooled in ice water and centrifuged. 
Step II. 
The reaction mixture contained in a final volume 
of 1 ml in a quartz cuvette; 0.2 mM orotate, 2 mM 
MgC12, 20 mM Tris-HC1 buffer, pH 7.6, 0.2 ml of 
orotidine-5'-phosphate pyrophosphorylase (EC
2.4.2.10) and orotidine-5'-phosphate decarboxylase 
(EC 4.1.1.23), and 0.3 ml of the step I incubation 
mixture. The pH of the reaction mixture in step II 
after addition of 0.3 ml step I was 7.6. The amount of 
orotidine-5'-phosphate pyrophosphorylase-decarboxy- 
lase used was chosen so that 25 nmoles of PRPP 
caused the disappearance of orotate within 30 min at 
room temperature (25°C). The disappearance of 
1/smole of orotate corresponded to a decrease in ab- 
sorbance of 3.95 at 295 nm [6]. 
Highly purified preparations of PRPP synthetase 
(3.5 ~moles/min/mg protein) were obtained from rat 
liver by the following procedure. Tissue was homo- 
genized in 0.1 M potassium phosphate and 1 mM 
dithioerythritol, centrifuged at 100 000 g for 30 min, 
precipitated with ammonium sulfate (40% saturation), 
brought o 65°C for 5 min, precipitated atpH 4.8 
and subjected to Sepharose 4B-200 gel filtration [8]. 
The determination f the protein content of the 
extracts [9] and the cell counts were made as cited 
previously [2]. 
All chemicals were of the highest purity grade 
available and the various compounds and ancillary 
enzymes were purchased from Sigma Chemical Co., 
St. Louis, Mo. From the stock solution of orotidine- 
5'-phosphate pyrophosphorylase-decarboxylase 
(2.8 mg/ml of 60 mM Tris-HC1, pH 7.5) appropriate 
dilutions were prepared immediately before the assays. 
@ 
3. Results and discussion 
3.1. Comparison of properties of PRPP synthetase 
from rat liver and hepatoma 3924A 
Both liver and hepatoma enzymes have an absolute 
requirement for inorganic phosphate, as have the en- 
zymes isolated from Salmonella typhimurium [ 10] 
and human red blood cells [11,12]. The pH optimum 
for the liver enzyme was 8.8 (shoulder at 6.9) and for 
the hepatoma 8.6 (shoulder at 7.2). For Mg-ATP, 
without excess Mg 2 ÷, a sigmoidal curve was observed. 
Additional Mg 2÷ converts the sigmoidal curves into 
hyperbolic ones. The apparent Km values for Mg-ATP, 
in the presence of 3 mM Mg 2÷ and 20 mM phosphate, 
were 0.3 and 0.6 mM for liver and hepatoma, respec- 
tively. Mg 2 ÷-ATP in concentrations higher than 3.0 
mM inhibited the enzyme. The Mg 2÷ saturation curves 
were sigmoidal and the half maximal activities at 20 
mM phosphate for liver and hepatoma were 0.5 and 0.6 
mM, respectively. For ribose-5-phosphate th appa- 
rent Km was 0.1 mM for both tissues and the sub- 
strate inhibited PRPP synthetase activity at concen- 
trations higher than 1.0 mM. Both liver and hepatoma 
PRPP synthetase were inactivated by p-chloromer- 
curiphenyl sulfonic acid, signalling the importance of 
sulfhydryl groups for the catalytic activity. These ob- 
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Table 1 
PRPP synthetase activity in neoplastic, regenerating, and differentiating rat liver 
Tiss ues Growth 
rate 
(weeks) 
PRPP synthetase activity (umoles per hr) 
per g wet weight per cell X 10 -a 
Normal iver (Buffalo) 
Control for 7777 
Control for 9618A2 
Normal aver [ACI/N) 
Control for 3924A 
Sham operated (Wistar) 
24 hr regenerating liver (Wistar) 
5-day-old liver 
Hepatomas 7777 
3924A 
9618A2 
4.1 
3.8 
2.3 
9.450.2 4.050.1 
10.8±0.5 7.2±0.3 
10.4 ± 0.2 5.7 ± 0.1 
8.8 ± 0.1 4.7 ± 0.1 
10.5 ± 0.5 (120) 5.6 ± 0.2 (118) 
9.3 ± 0.3 (89) 1.5 ± 0.1 ( 32)* 
14.0 ± 0.4 (149)* 5.8 ± 0.2 (147)* 
19.5 ± 0.4 (187)* 11.5 ± 0.2 (202)* 
18.5 ± 1.1 (172)* 11.9 ± 0.7 (166)* 
The data are means ± S.E. of 4 experiments with percentages ofcorresponding control 
5ver values in parentheses. The activities per cell are to be multiplied with the exponen- 
tial given to arrive at the actual numbers. 
*Values tatistically significantly different from the respective controls (p < 0.05). 
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servations indicated that the PRPP synthetase was 
kinetically similar in the fiver and in the rapidly grow- 
ing hepatoma 3924A. 
The enzyme preparations catalyzed the formation 
of ATP and ribose-5-phosphate from PRPP and AMP, 
indicating reversibility of  the reaction. Determination 
of the equilibrium constant will be reported elsewhere 
[8]. 
3.2. Activity of PRPP synthetase in extracts of diffe- 
rent rat tissues 
The specific activities of  PRPP synthetase as per- 
centages of  normal iver were the following: brain 
308, thymus 220, heart 147, spleen 125, liver 100, 
intestinal mucosa 75, lung 60, kidney 50, and muscle 
28. The brain and thymus which have high RNA and 
DNA synthesis have the highest, whereas keletal 
muscle has the lowest, enzyme activity. 
3.3. PRPP synthetase activity in normal, differer~ 
tiating and regenerating liver and in rapidly gro- 
wing hepatomas 
In table 1 PRPP synthetase activity is expressed per 
gram wet weight and per average cell. In the average 
cell of the rapidly growing hepatoma, 7777, 3924A 
and 9618A2, the PRPP synthetase activity was signi- 
ficantly increased 1.5 to 2.0-fold over that of the 
control normal iver. In contrast, the enzyme activity 
in the regenerating liver was in normal range and in 
the differentiating liver it was 40% of the activity of 
the adult rat. The results were similar when the activity 
was expressed on a per gram wet weight of tissue 
basis (table 1). 
4. Conclusions 
The reprogramming of gene expression that occurs 
in the neoplastic transformation of the liver entails 
in addition to the increase in the activities of the key 
enzymes of glycolysis and pentose phosphate syn- 
thesis also a rise in the activity of PRPP synthetase 
which is the first enzyme committed to the channe- 
ling of ribose-5-phosphate into purine biosynthesis. 
This alteration in the expression of gene program 
should provide selective advantages for the cancer cell. 
The increase in PRPP'synthetase activity in the 
rapidly growing hepatomas appears to be specific to 
neoplastic rapid growth rate; since no similar alteration 
is observed in the rapidly growing regenerating ordiffe- 
rentiating liver. In view of these considerations PRPP 
synthetase might be an important target in the design of 
selective chemotherapy. The molecular and regulatory 
properties of this enzyme are under investigation. 
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